Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000530824 | SCV000632085 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001573356 | SCV005296409 | benign | not provided | criteria provided, single submitter | not provided | ||
Athena Diagnostics | RCV001727741 | SCV005621093 | benign | not specified | 2024-06-04 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV001573356 | SCV001799120 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727741 | SCV001973412 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004541660 | SCV004767125 | benign | CACNA1H-related disorder | 2019-04-10 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |